Dr. Joseph J. Merchant
Claim this profileMcFarland Clinic - Ames
Expert in Cancer
Expert in Lung Cancer
88 reported clinical trials
141 drugs studied
About Joseph J. Merchant
Education:
- Obtained a BA from the University of Notre Dame (1983-1987).
- Earned an MD from the University of Iowa College of Medicine (1988-1992).
Experience:
- Completed a Residency in Internal Medicine at the University of Virginia Medical Center (1993-1996).
- Undertook a Fellowship in Hematology and Medical Oncology at the University of Wisconsin Comprehensive Cancer Center.
- Has been with McFarland Clinic since August 2002, providing outreach services in Jefferson and Marshalltown, Iowa.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Joseph J. Merchant is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
More about Joseph J. Merchant
Clinical Trial Related4 years of experience running clinical trials · Led 88 trials as a Principal Investigator · 68 Active Clinical TrialsTreatments Joseph J. Merchant has experience with
- Nivolumab
- Carboplatin
- Pembrolizumab
- Atezolizumab
- Paclitaxel
- Cisplatin
Breakdown of trials Joseph J. Merchant has run
Cancer
Lung Cancer
Breast Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph J. Merchant specialize in?
Joseph J. Merchant focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Joseph J. Merchant currently recruiting for clinical trials?
Yes, Joseph J. Merchant is currently recruiting for 64 clinical trials in Ames Iowa. If you're interested in participating, you should apply.
Are there any treatments that Joseph J. Merchant has studied deeply?
Yes, Joseph J. Merchant has studied treatments such as Nivolumab, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Joseph J. Merchant?
Apply for one of the trials that Joseph J. Merchant is conducting.
What is the office address of Joseph J. Merchant?
The office of Joseph J. Merchant is located at: McFarland Clinic - Ames, Ames, Iowa 50010 United States. This is the address for their practice at the McFarland Clinic - Ames.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.